OpenVSafe by OpenVAERS
Search V-safe

Y85-88753-61955

2 vaccinations 12 coded responses 21 check-ins 12 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
871 / NM
Registered
2021-01-12
Relationship
Self
Race
American Indian or Alaska Native
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-08
    Dose 1 — Moderna
  2. 2021-01-12
    Registered in v-safe
  3. 2021-01-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Respiratory tract congestion — Feeling: Fair · Site: Pain · Nausea
    Free text: Congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-15
    Survey response — day 7, dose 1
    MedDRA: Respiratory tract congestion — Feeling: Fair · Fatigue or tiredness, Nausea
    Free text: Congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-22
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  7. 2021-01-29
    Survey response — day 21, dose 1
    MedDRA: Abnormal faeces, Decreased appetite, Nausea, Rash — Feeling: Fair
    Free text: Digestion concerns. Not severe enough to see a health care provider, but very concerning to see abnormal feces. Other concerns involve a change in skin condition from clear to breakouts. Final concern is a lack of appetite and nausea.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-05
    Dose 2 — Moderna
  9. 2021-02-05
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  10. 2021-02-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dehydration, Dry eye, Nasal congestion — Feeling: Poor · Site: Pain, Redness, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Dehydrated. Dry eyes. Nasal congestion.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dehydration, Nasal congestion — Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Nasal congestion. Dehydration.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dehydration, Nasal congestion — Feeling: Fair · Site: Pain, Itching
    Free text: Nasal congestion and dehydration.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dehydration, Nasal congestion, Respiratory tract congestion — Feeling: Good · Site: Pain, Itching · Diarrhea, Rash, not including the immediate area around the injection site
    Free text: Dehydration, nasal and chest congestion.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dehydration, Nasal congestion — Feeling: Good · Site: Itching · Fatigue or tiredness
    Free text: Nasal congestion and dehydration.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dehydration, Nasal congestion — Feeling: Good
    Free text: Dehydration and slight nasal congestion.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-12
    Survey response — day 7, dose 2
    MedDRA: Dehydration — Feeling: Good
    Free text: dehydration
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-26
    Survey response — day 21, dose 2
    MedDRA: Rash — Feeling: Good
    Free text: Mild skin rash on fore arms and biceps during the day and at end of the day, shortly before bedtime, the rash becomes slightly moderate. Appears to be similar to eczema symptoms. In addition, symptoms persist in dehydration.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-12
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-07
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-08-06
    Survey response — 6 months, dose 2
    MedDRA: Rash — Feeling: Good
    Free text: Reoccurring skin rash that flares up unexpectedly on one side of body above the waist or sometimes both sides.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2022-02-07
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-08Moderna
22021-02-05Moderna

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-12

Systemic reaction (other): Congestion

Release 2 — day 7, dose 1

2021-01-15

Systemic reaction (other): Congestion

Release 3 — day 21, dose 1

2021-01-29

Symptoms: Digestion concerns. Not severe enough to see a health care provider, but very concerning to see abnormal feces. Other concerns involve a change in skin condition from clear to breakouts. Final concern is a lack of appetite and nausea.

Release 3 — days 1–6 daily, dose 2

2021-02-06

Systemic reaction (other): Dehydrated. Dry eyes. Nasal congestion.

2021-02-07

Systemic reaction (other): Nasal congestion. Dehydration.

2021-02-08

Systemic reaction (other): Nasal congestion and dehydration.

2021-02-09

Systemic reaction (other): Dehydration, nasal and chest congestion.

Release 4 — days 1–6 daily, dose 2

2021-02-10

Systemic reaction (other): Nasal congestion and dehydration.

2021-02-11

Systemic reaction (other): Dehydration and slight nasal congestion.

Release 4 — day 7, dose 2

2021-02-12

Systemic reaction (other): dehydration

Release 4 — day 21, dose 2

2021-02-26

Symptoms: Mild skin rash on fore arms and biceps during the day and at end of the day, shortly before bedtime, the rash becomes slightly moderate. Appears to be similar to eczema symptoms. In addition, symptoms persist in dehydration.

Release 9 — 6 months, dose 2

2021-08-06

Symptoms: Reoccurring skin rash that flares up unexpectedly on one side of body above the waist or sometimes both sides.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbnormal faeces ✓ ✓ ✓
SDDecreased appetite ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDRash ✓ ✓ ✓
SRODehydration ✓ ✓ ✓
SRODry eye ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SRORespiratory tract congestion ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release